LexDanaLexDanabeta
Inventor

Qi-Yin CHEN

Inventor
US

Overview

2→
Patents
2023–2026
Patent span
Human necessities
Primary field (CPC A)

Patents· 2 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
C07DHeterocyclic compounds29%
A01NPreservation of bodies of humans or animals or plants or parts thereof14%
A61KPreparations for medical, dental or toiletry purposes14%
C07KPeptides14%
PatentTitleYear
12,565,474Discovery, total synthesis, and bioactivity of doscadenamides202611,718,645Macrocyclic therapeutic agents, methods of manufacture, and methods of treatment2023

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2023–2026Patents assigned to UNIV FLORIDA (2)· patent assignee history
2023–2026Based in US· patent location history
2026Patents assigned to SMITHSONIAN INST (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
UNIV FLORIDA22023–2026
SMITHSONIAN INST12026
Locations
LocationPatentsSpan
US22023–2026